![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Viropro Inc (CE) | USOTC:VPRO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Nevada
|
333-06718
|
13-3124057
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
4199 Campus Drive
Suite 550
Irvine CA
|
92612
|
|
(Address of principal executive offices)
|
(Zip Code)
|
[ ]
|
[ ]
|
[ ]
|
[ ]
|
|
a)
|
February 22, 2011
|
|
b)
|
Through a Share Purchase Agreement, Viropro Inc acquires 100 % of Alpha Biologics Sdn. Bhd. of Penang, Malaysia, a contract process development and GMP biomanufacturing company, with process development laboratories located in Cambridge, UK and a GMP mammalian cell clinical production facility located in the Penang Science Park.
|
|
c)
|
|
|
a.
|
Springhill Bioventures Sdn Bhd
|
|
b.
|
THG Capital Sdn Bhd
|
|
c.
|
Michelle Leanne Edythe Peake
|
|
d)
|
Viropro shall issue 525,000,000 restricted shares valued at US$0.04 each, representing a total value of US$21 million. The offer and sale of the shares was made pursuant to a non-US person pursuant to Rule 903(b)(3).
|
1 Year Viropro (CE) Chart |
1 Month Viropro (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions